Image via Pharma Times
Last updated
MSD: Product Launch
MSD's pembrolizumab received NICE recommendation for locally advanced cervical cancer (LACC), representing first immunotherapy approval in this indication in England
Source: Pharma Times
The leadership read
Product momentum tends to widen technology product and commercial leadership bench strength.
Market context: This lands while the Talent Market Index reads 108 (Hot) — up 2.4 versus the prior month — and EMEA signal share is easing (-8.7pts).
MSD: 1 signal in the last 90 days — in line with the Technology median of 1 across 205 tracked companies; 0.1% of MitchelLake's EMEA signal flow.
MitchelLake in this thematic
From the MitchelLake archive
More signals across Technology
Product Launch · EMEA
DocuSign →DocuSign unveiled new AI-powered agreement tools at Momentum London conference, including the Iris AI engine and customizable agents designed to accelerate contract workflows for enterprise customers.
Product Launch · EMEA
CSL →CSL's Tavenos product faced a regulatory setback in the European Union, flagged as a potential challenge to the biotechnology major
Product Launch · EMEA
Light & Wonder →Light & Wonder launched Galeforce, a new game development studio, to expand operations in the EMEA (Europe, Middle East, Africa) region.
Product Launch · EMEA
Entrust →Entrust launched Entrust Biometric Authentication, a new product combining biometric identity verification with adaptive risk-based authentication to combat AI-powered account takeover fraud. The solution includes three authentication methods: Biometric Passkey, Face Authentication, and Motion Authentication with liveness detection.
Product Launch · EMEA
Telia →Telia launched Telia Critical IoT Connectivity, a commercial SA 5G-based IoT service in Sweden targeting emergency services, energy, transport, industry and healthcare sectors. This is the company's second major IoT product announcement in a month, following May's Telia IoT Connect.
Product Launch · EMEA
Sage →Sage is promoting e-invoicing solutions as a strategic product to address UK SME payment delays, with government mandate coming in 2029. This represents significant product positioning and market expansion opportunity
Intelligence powered by Autonodal ↗